WilmerHale Represents Medtronic in its $2.0B Offering of Senior Notes

WilmerHale Represents Medtronic in its $2.0B Offering of Senior Notes

Client News

Related Solutions

Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
Comprehensive counseling for healthcare providers, insurers and the companies that supply them with products and services.

WilmerHale represented Medtronic Global Holdings S.C.A., a wholly-owned subsidiary of Medtronic plc, a global leader in healthcare technology, in connection with its recent public offering of $1.0 billion aggregate principal amount of 4.250% Senior Notes due 2028 and $1.0 billion aggregate principal amount of 4.500% Senior Notes due 2033. Net proceeds from the offering will be used to repay outstanding indebtedness. The transaction closed on March 30, 2023.

The WilmerHale team representing Medtronic was led by corporate partners Erika Robinson, Justin Ochs and Craig Hilts, counsel Andrew Langworthy, senior associate Leigh Krafchek, associate Shaina Hourizadeh, and included associate Ben Lobley.

For more information, read Medtronic’s press release.

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel